Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
TechGuru's Profile
Displaying 301-350 of 1386 result(s).
CYDY CytoDyn Inc
11/01/2020 12:17:13 PM
This is from a couple of days back: (15)
CYDY CytoDyn Inc
11/01/2020 12:07:36 PM
Expharmer, Please check PM. TechGur
CYDY CytoDyn Inc
10/30/2020 9:49:14 AM
Nicehedges, Thank you. Have been wa (2)
CYDY CytoDyn Inc
10/27/2020 9:07:00 AM
For me the real importance of the M (18)
CYDY CytoDyn Inc
10/26/2020 5:14:41 PM
SAF, The evidence will show up. One (1)
CYDY CytoDyn Inc
10/26/2020 4:58:00 PM
While investigators initially didn' (2)
CYDY CytoDyn Inc
10/25/2020 3:43:40 PM
Something we seem to have forgotten (20)
CYDY CytoDyn Inc
10/25/2020 11:34:13 AM
Havasu, Trying to answer your quest (4)
CYDY CytoDyn Inc
10/25/2020 10:32:50 AM
Ohm, My Post-hoc power calculation (3)
CYDY CytoDyn Inc
10/25/2020 10:08:42 AM
Blafarm, Thanks for your feedback. (7)
CYDY CytoDyn Inc
10/24/2020 2:37:43 PM
Good morning to you all. Have been (24)
CYDY CytoDyn Inc
10/23/2020 5:21:34 PM
Nicehedges, Thanks for posting this (2)
CYDY CytoDyn Inc
10/23/2020 2:16:33 PM
The Remdesivir approval speaks volu (18)
CYDY CytoDyn Inc
10/22/2020 9:47:42 AM
KenShowder, In my case, these are n (2)
CYDY CytoDyn Inc
10/22/2020 9:04:45 AM
SeeWhyDY, This is is why are a comp (14)
CYDY CytoDyn Inc
10/21/2020 6:24:08 PM
Faucci (NIH) pushed GILD https://ww
CYDY CytoDyn Inc
10/21/2020 3:09:07 PM
As some of you have already stated (16)
CYDY CytoDyn Inc
10/20/2020 8:48:25 AM
This is a very interesting question (2)
CYDY CytoDyn Inc
10/20/2020 8:37:04 AM
So, this is the news we were expect (24)
CYDY CytoDyn Inc
10/19/2020 12:20:59 PM
Nmbr1stckpckr, I respectfully disag (10)
CYDY CytoDyn Inc
10/19/2020 8:24:59 AM
Some food for thought. Out trial is (10)
CYDY CytoDyn Inc
10/19/2020 7:41:45 AM
If Dr. Patterson wants leronlimab f (4)
CYDY CytoDyn Inc
10/18/2020 7:58:45 AM
Ohm, Thanks for the valuable inform (2)
CYDY CytoDyn Inc
10/17/2020 2:34:08 PM
Maybe has been posted here before ? (4)
CYDY CytoDyn Inc
10/17/2020 2:23:10 PM
Cassandra, Help with full enrollmen (8)
CYDY CytoDyn Inc
10/17/2020 12:38:47 PM
Ohm, Yes. This is precisely what is (7)
CYDY CytoDyn Inc
10/17/2020 10:01:52 AM
This was posted here before. NIH be (7)
CYDY CytoDyn Inc
10/17/2020 9:11:21 AM
Absolutely. This will be achieved w (4)
CYDY CytoDyn Inc
10/17/2020 7:25:08 AM
Ohm, Dr. Hahn's comment on the gold (7)
CYDY CytoDyn Inc
10/16/2020 2:33:52 PM
Dr. Acula, Gilead was the first to
CYDY CytoDyn Inc
10/16/2020 11:30:38 AM
I have been an investor in CYDY for (19)
CYDY CytoDyn Inc
10/15/2020 10:10:24 PM
These are our CD-12 trial measures: (8)
CYDY CytoDyn Inc
10/13/2020 10:04:37 AM
Onestepahead, I would imagine that (2)
CYDY CytoDyn Inc
10/13/2020 9:34:57 AM
Respert, Good point as we are now i (6)
CYDY CytoDyn Inc
10/13/2020 8:55:43 AM
To register leronlimab (PRO 140) fo (2)
CYDY CytoDyn Inc
10/12/2020 8:19:59 AM
I mentioned this before, but this i (10)
CYDY CytoDyn Inc
10/08/2020 12:14:45 PM
CDiddy, Yes. You are right, is in f (1)
CYDY CytoDyn Inc
10/08/2020 10:41:19 AM
PatientLong, I think you could say (3)
CYDY CytoDyn Inc
10/08/2020 8:28:44 AM
Interesting discussion on p-values. (12)
CYDY CytoDyn Inc
10/08/2020 7:50:50 AM
JLang, Give to Caesar what belongs (2)
CYDY CytoDyn Inc
10/07/2020 5:24:51 PM
JLang, NP mentioned in the intervie (4)
CYDY CytoDyn Inc
10/07/2020 3:20:06 PM
Nader did what a good CEO should ha (24)
CYDY CytoDyn Inc
10/07/2020 11:16:33 AM
CDiddy, Not only that. The safety b (5)
CYDY CytoDyn Inc
10/07/2020 9:08:45 AM
I meet you guys in a beach in Thail (6)
CYDY CytoDyn Inc
10/07/2020 8:40:04 AM
Cycl2R, Trials for definition have (7)
CYDY CytoDyn Inc
10/07/2020 8:31:55 AM
DaveEL, Good work. Your numbers are (5)
CYDY CytoDyn Inc
10/06/2020 6:11:28 PM
Dvb, In cases where there are two g (9)
CYDY CytoDyn Inc
10/06/2020 7:46:27 AM
As we anxiously await the results f (22)
CYDY CytoDyn Inc
10/04/2020 11:44:17 AM
MD Virologist, Looking forward to r
CYDY CytoDyn Inc
10/04/2020 8:27:06 AM
This is VERY worrying .... The US n (3)
Go to page:
  • << First
  • < Previous
  • 6
  • 7
  • Next >

Recent Articles

  • Celebrating Financial Health: Global Impact Champions Awards Launch
  • Avast Emerges as the Top Choice for Antivirus Software
  • FAA Implements Changes to Helicopter Routes after Tragedy
  • Navigating High-Beta Stocks: Echoes of the Dot-Com Boom
  • Understanding the Real Dynamics Behind Portfolio Performance
  • Overview of Financière de Tubize’s Half-Year Performance
  • Financière de Tubize Unveils Promising Financial Results for 2025
  • Legal Actions from Shareholders: Insights on Sarepta and Petco
  • Kuvi.ai Unveils Agentic Finance OS in Seed Funding Expansion
  • SHARC Energy Advancing Financing with New Convertible Debentures
  • Important Class Action Update for Hims & Hers Health Investors
  • Class Action Lawsuit Emerges Against Flywire Corporation
  • Important Update for Sable Offshore Investors: Act Now
  • Class Action Notice for Neogen Investors: Key Details Inside
  • Tempus AI Faces Legal Challenges Following SEC Allegations
  • Replimune Group Faces Class Action: Key Insights for Investors
  • Neogen Corporation Investors Can Join Class Action Efforts
  • Key Actions for Luminar Technologies Investors Amid Class Action
  • Investors Urged to Act: RxSight Class Action Deadline Approaches
  • Sable Offshore Corp. Class Action: Important Actions for Investors
  • Protecting Your Rights Following Securities Claims with TRSG
  • Investors of Fiserv, Inc. Can Join Class Action for Losses
  • Kepler's K2 Humanoid Robot Revolutionizes Industrial Automation
  • Investor Rights Firm Investigates Potential Mergers and Sales
  • Investigating Stockholder Rights: Olo, Fubo, Arcadia, and Norfolk
  • RxSight Inc. Faces Class Action Lawsuit Over Misleading Claims
  • Spitzer Autoworld Elevates Customer Experience with New VIP Program
  • HashJ Launches New BTC Participation Contracts Amid Market Shift
  • Experience Vibrant Music Events at Great Park Live This Season
  • Explore OLIVE YOUNG's K-Beauty Innovations at KCON LA 2025
  • Discovering the Exceptional Growth of Gartner Stock Today
  • Investors of Sable Offshore Corp. Encouraged to File Claims
  • Senate Bill Secures Funding for OSHA and NIOSH - A Win for Safety
  • Arteris, Inc. Boosts Team with New Inducement Stock Awards
  • Investing in Ameriprise Financial: A 5-Year Review
  • Grupo Cox Makes Major Investment with Iberdrola Acquisition
  • First National Bank Alaska Announces Strong Q3 Dividend Strategy
  • Understanding the Long-Term Value of American Express Stock
  • First National Bank Alaska Announces Third Quarter Dividend
  • Project 61 and Offshift Join Forces for Truck Driver Health
  • Keg Royalties Income Fund Secures Approval for Fairfax Deal
  • The Keg Royalties Income Fund Secures Approval for Key Deal
  • Unlocking the Wealth from Shopify: 15 Years of Growth Insights
  • Lara's Rate Hikes: Consumers Left in Uncertainty Amid Secrecy
  • Barrett-Jackson Holdings Responds to Customer Data Breach
  • A Decade of Growth: $100 in Live Nation Entertainment's Journey
  • Crypto Market Surges—Will the Bull Momentum Continue?
  • Hims & Hers: A Bright Future Amidst Market Challenges
  • OZAK AI Raises $1.5M in Presale, Captivating AI Investors
  • Investigation into Corporate Governance of Key Companies
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site